Skip to main content
OpenTrials
Completed

NCT Number: NCT02230007

Contribution of the MEOPA in the Physiotherapy Care of Painful Articular Steepness Among Elderly

The MEOPA is used to obtain an analgesia of the short-term painful acts. To the population of elderly patients, the therapeutic resources to control the passing pain require in their manipulation a certain caution and are not divested of side effects badly tolerated at this age. An alternative in the opioid presents all its interest. The MEOPA is here an alternative of choice in the care of these pains, in particular in case of pre-existent cognitive achievement, of polypathologies or of polymédication.

The gas MEOPA administered to the mask could thus be an effective additive in the physiotherapy treatment of the elderly person.

The main objective is to Assess the efficacy , in terms of recovery of the hip and knee joint articular amplitude, of 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Management and Care Agnosia Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pathological Conditions, Signs and Symptoms Perceptual Disorders Signs and Symptoms

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

CHU de Nice, Nice, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female aged 65 years old or more
  • Patients having a prescription for physiotherapy
  • Absence of contraindication to MEOPA
  • Patients whose initial assessment show a passive articular deficit of at least a joint of hip or the knee and whose painful assessment is ≥ 5 or ≥ 2 during mobilisation on the validated scale Algoplus
  • Patients whose reeducation project established by the physiotherapist
  • Patients having agreed to participate in the study and having signed the consent
  • Subjects affiliated to the social security system

Exclusion criteria

  • Patient requiring a ventilation in pure oxygen
  • Patient with a consciousness deterioration preventing his cooperation
  • Care under MEOPA during the period of the protocol and during the month which precedes
  • Increase of the dosage of morphine of less than 48 hours Patient under guardianship

Treatment and study plan

MEOPA

Drug

3 sessions of reeducation using MEOPA

Primary outcomes

  1. % of recovery of the hip and knee joint articular amplitude

    Time frame: 5 days

    % of recovery of the hip and knee joint articular amplitude during 5 days after 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment; measure % of recovery of the hip and knee joint articular amplitude two times : before the beginning of the session of reeducation and at the end of the session

Secondary outcomes

  1. Measure of the pain

    Time frame: 5 days

    Patient answer a questionnaire on his pain at the beginning of each session of reeducation (5 sessions)

  2. Patients'satisfaction

    Time frame: End of the period of care (up to 5 days)

    Patient answer a questionnaire on this satisfaction at the end of the period of care of the protocol.

  3. Physiotherapists'satisfaction

    Time frame: End of all the period of care (up to 5 days)

    Physiotherapists answer a questionnaire on this satisfaction of the use of the MEOPA

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Sep 3, 2014
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.